A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically.

MLA

Coffee, Bradford, et al. “A Substantial Proportion of Apparently Heterozygous TP53 Pathogenic Variants Detected with a Next-Generation Sequencing Hereditary Pan-Cancer Panel Are Acquired Somatically.” Human Mutation, vol. 41, no. 1, Jan. 2020, pp. 203–11. EBSCOhost, https://doi.org/10.1002/humu.23910.

APA

Coffee, B., Cox, H. C., Bernhisel, R., Manley, S., Bowles, K., Roa, B. B., & Mancini-DiNardo, D. (2020). A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically. Human Mutation, 41(1), 203–211. https://doi.org/10.1002/humu.23910

Chicago

Coffee, Bradford, Hannah C Cox, Ryan Bernhisel, Susan Manley, Karla Bowles, Benjamin B Roa, and Debora Mancini-DiNardo. 2020. “A Substantial Proportion of Apparently Heterozygous TP53 Pathogenic Variants Detected with a Next-Generation Sequencing Hereditary Pan-Cancer Panel Are Acquired Somatically.” Human Mutation 41 (1): 203–11. doi:10.1002/humu.23910.